Sotac Pharmaceuticals

Sotac Pharmaceuticals EBIT Margin

The EBIT Margin (Operating Margin) of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 19, 2026 is 10.12 %. In the previous year, EBIT Margin (Operating Margin) was 4.99 % — a change of 102.79% (higher).

EBIT Margin

10.12 %

YoY

102.79%

Last updated:

EBIT Margin (Operating Margin) of Sotac Pharmaceuticals is 2025 10.12 % . EBIT Margin (Operating Margin) of Sotac Pharmaceuticals was 2024 4.99 % . It decreases by 102.79% higher compared to the previous year.

For Sotac Pharmaceuticals, the operating (EBIT) margin of 10.1% is up versus -2.3% a few years ago.

The Sotac Pharmaceuticals EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2020
1.61 INR
Jan 1, 2021
-2.33 INR
Jan 1, 2022
9.36 INR
Jan 1, 2023
11.35 INR
Jan 1, 2024
4.99 INR
Jan 1, 2025
10.12 INR
The Sotac Pharmaceuticals EBIT Margin history
YEAREBIT MarginYoY
10.12 %+102.79%
4.99 %-56.05%
11.35 %+21.34%
9.36 %-501.30%
-2.33 %-244.45%
1.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd., headquartered in Ahmedabad, Gujarat, operates in the Health Care sector, specializing in pharmaceutical manufacturing. The company develops and manufactures products such as Non Beta-Lactam tablets, capsules, syrups, and external preparations on a contract basis for various marketers. Its therapeutic portfolio covers Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Anti-Cold, Anti-Allergic, Derma Products, and a wide range of antibiotics including Non-IP-Lactams and Cephalosporin. Listed on 13 April 2023, Sotac employs 89 people and has subsidiaries including SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

EBIT Margin (Operating Margin) of Sotac Pharmaceuticals is 10.12 % in 2025.

EBIT Margin (Operating Margin) of Sotac Pharmaceuticals changed from 4.99 % to 10.12 %, representing a 102.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Sotac Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Sotac Pharmaceuticals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Sotac Pharmaceuticals